College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250355, PR China.
Experimental Center, Shandong University of Traditional Chinese Medicine, Jinan 250355, PR China.
Biomed Pharmacother. 2023 Mar;159:114273. doi: 10.1016/j.biopha.2023.114273. Epub 2023 Jan 23.
Ulcerative Colitis (UC) is a chronic disease, in the progression of which an immune overreaction may play an important role. IL-22 is a member of the IL-10 superfamily of cytokines and is pleiotropic in immune regulation and inflammatory responses. IL-22 can produce protective effects, promote wound healing and tissue regeneration, while it can also induce inflammatory reactions when it is chronically overexpressed. Extensive literatures reported that IL-22 played an essential role in the pathogenic development of UC. IL-22 participates in the whole disease process of UC involving signaling pathways, gene expression regulation, and intestinal flora imbalance, making IL-22 a possible candidate for the treatment of UC. In this paper, the latest knowledge to further elucidate the role of IL-22 in UC was summarized and analyzed.
溃疡性结肠炎(UC)是一种慢性疾病,其进展过程中免疫过度反应可能发挥重要作用。白细胞介素 22(IL-22)是白细胞介素 10 超家族细胞因子的成员,在免疫调节和炎症反应中具有多效性。IL-22 可产生保护作用,促进伤口愈合和组织再生,但当它慢性过表达时也会引起炎症反应。大量文献报道 IL-22 在 UC 的发病机制中起重要作用。IL-22 参与 UC 的整个疾病过程,涉及信号通路、基因表达调控和肠道菌群失衡,使 IL-22 成为 UC 治疗的一个潜在候选药物。本文对进一步阐明 IL-22 在 UC 中的作用的最新知识进行了总结和分析。
Biomed Pharmacother. 2023-3
Eur Rev Med Pharmacol Sci. 2018-8
World J Gastroenterol. 2013-5-7
Biosci Rep. 2018-11-28
Nan Fang Yi Ke Da Xue Xue Bao. 2016-12-20
J Basic Clin Physiol Pharmacol. 2018-12-19
Nan Fang Yi Ke Da Xue Xue Bao. 2025-8-20
World J Gastrointest Oncol. 2025-6-15